Effect of rosuvastatin on repeat heart failure hospitalizations: the corona trial (controlled rosuvastatin multinational trial in heart failure)
<p style="text-align:justify;"> <b>Objectives:</b> This study sought to examine the effect of statin therapy hospitalizations for heart failure (HFH) in patients in the CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure) trial.<br/><br/> <...
Κύριοι συγγραφείς: | Rogers, J, Jhund, P, Perez, A, Böhm, M, Cleland, J, Gullestad, L, Kjekshus, J, Van Veldhuisen, D, Wikstrand, J, Wedel, H, McMurray, J, Pocock, S |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Elsevier
2014
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
ανά: Erik Tandberg Askevold, κ.ά.
Έκδοση: (2015-01-01) -
Rosuvastatin in older patients with systolic heart failure.
ανά: Florkowski, C, κ.ά.
Έκδοση: (2008) -
Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis
ανά: Kotecha, D, κ.ά.
Έκδοση: (2017) -
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
ανά: Cleland, J, κ.ά.
Έκδοση: (2017) -
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
ανά: Gounari, P, κ.ά.
Έκδοση: (2010)